Riyam Al Msari

Also affiliated with UC San Diego Health System, University of California San Diego, Allen Institute, Koch Institute for Integrative Cancer Research At MIT, Massachusetts Institute of Technology

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC”.

Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC

Nature Communications(2022)10.1038/s41467-022-31941-w

N/A

0DataRank · unranked

176 citations

Aoife O’Farrell, Farhoud Faraji, Lauren Clubb, Michael M. Allevato, Shawn M. Jensen +17 more

Lymphatic-Preserving Treatment Sequencing with Immune Checkpoint Inhibition Unleashes cDC1-Dependent Antitumor Immunity in HNSCC

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.01.478744

N/A

0DataRank · unranked

9 citations

Aoife O’Farrell, Farhoud Faraji, Lauren Clubb, Michael M. Allevato, Nana-Ama A.S. Anang +16 more